You are here

Japan

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M

Fierce Pharma

Wed, 01/4/23 - 10:21 am

Moderna Therapeutics

OriCiro Genomics

Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences

NASDAQ.com

Thu, 12/8/22 - 10:03 am

Gilead Sciences

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck

Fierce Pharma

Tue, 11/22/22 - 04:28 pm

Medtronic's Hugo Clears 3 Major Regulatory Hurdles

Medical Devices and Diagnostics Industry

Thu, 10/20/22 - 10:28 am

robotic surgery

Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization

Fierce Pharma

Tue, 10/4/22 - 10:42 am

intranasal vaccines

Daiichi Sankyo's Ezharmia Becomes First EZH1/2 Inhibitor for Blood Cancer

BioSpace

Mon, 09/26/22 - 11:32 pm

relapsed or refractory adult T-cell leukemia/lymphoma

AstraZeneca's Evusheld nabs its first global nod as a COVID treatment

Fierce Pharma

Wed, 08/31/22 - 10:34 pm

Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna

BioSpace

Tue, 05/31/22 - 10:32 am

Moderna Therapeutics

Sanofi's Xenpozyme gets approval in Japan for rare genetic disease

Seeking Alpha

Mon, 03/28/22 - 10:30 am

Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial

Fierce Biotech

Fri, 03/4/22 - 09:46 am

Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market

Fierce Biotech

Mon, 02/28/22 - 11:19 am

Amgen Snags Another Approval for This Promising Cancer Drug

Motley Fool

Wed, 02/16/22 - 10:48 am

non-small cell lung cancer

advanced non-small cell lung cancer

Daiichi makes play for share of Japan’s COVID booster market

Pharmaforum

Mon, 01/31/22 - 10:49 am

Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators

Fierce Pharma

Wed, 12/22/21 - 11:06 am

Alzheimer's disease

Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan

Fierce Pharma

Wed, 11/10/21 - 09:32 pm

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

Pharmaforum

Mon, 09/27/21 - 10:49 am

Crohn's Disease

Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says

Fierce Pharma

Tue, 09/14/21 - 10:45 pm

Moderna Therapeutics

Merck Investors Have Reason to Cheer This Label Expansion

Motley Fool

Thu, 09/9/21 - 10:54 am

triple negative breast cancer

Takeda fleshes out CNS pact with peptide drugmaker, setting aside $3.5B in future milestones

Endpoints

Tue, 07/27/21 - 10:31 am

Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure

Endpoints

Fri, 06/11/21 - 10:56 am

Pages